Stocktoria
BillionToOne, Inc. BLLN
Nasdaq · XNAS · stock · Services-Medical Laboratories · website · IPO 2025-11-06
BillionToOne, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 |
|---|---|---|
| Gross margin | 68.3% | 53.0% |
| Operating margin | 5.3% | -30.9% |
| Net margin | 2.4% | -27.2% |
| FCF margin | 5.2% | -30.7% |
| Return on assets | 1.2% | -13.8% |
| Return on equity | 1.6% | 16.5% |
| Debt / equity | 0.12× | -0.20× |
| Current ratio | 11.69 | 8.03 |
| Revenue growth | 100.0% | — |
Source: SEC EDGAR filings · CIK 0002070849 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.